Transforming high-throughput screening with mass spectrometry
Drug Discovery World
OCTOBER 14, 2022
Büttner and colleagues, Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. Use of timsTOF technology has, therefore, triggered a paradigm change in life science analytics, enabling new levels of depth and coverage, for example in TIMS enabled 4D omics and tissue imaging MS applications. . KG, Biberach, Germany.
Let's personalize your content